{"id":"W3048507351","doi":"10.1016/j.ekir.2020.08.003","title":"Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy","year":2020,"lang":"en","type":"article","venue":"Kidney International Reports","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Omeros Corporation","keywords":"Medicine; Tolerability; Proteinuria; Adverse effect; Dosing; Internal medicine; Renal function; Nephropathy; Urology; Gastroenterology; Endocrinology; Kidney","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001782798,0.0004103571,0.0007747219,0.0001737617,0.000221926,0.0005179375,0.000343373,0.0005729268,0.001199468],"category_scores_gemma":[0.001307427,0.0001970984,0.0007347678,0.0001501513,0.0003025471,0.0004176264,0.0001559385,0.001070389,0.000276254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003929871,"about_ca_system_score_gemma":0.0004282621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003707022,"about_ca_topic_score_gemma":0.0006695084,"domain_scores_codex":[0.9993619,0.0003122644,0.00005577052,0.00007314805,0.0001368261,0.00006005084],"domain_scores_gemma":[0.9989854,0.0002297875,0.0004494823,0.00006635069,0.0001148083,0.000154281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3412507,0.02041846,0.06853365,0.002058222,0.002635811,0.001023649,0.0006349622,0.003775206,0.1565695,0.0001725194,0.004132359,0.3987951],"study_design_scores_gemma":[0.06428716,0.667383,0.2268216,0.0001668808,0.001904368,0.003065066,0.0001799809,0.003114196,0.02480774,0.0001798665,0.008023027,0.00006711928],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925903,0.005634265,0.0003861234,0.0002203229,0.00004017953,0.0001437653,0.0002995825,0.0000368043,0.0006485906],"genre_scores_gemma":[0.997833,0.0009235739,0.0002183226,0.0001750381,0.00009795291,0.00007816231,0.0003761459,0.000006128816,0.0002918291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001782798,"threshold_uncertainty_score":0.009428501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0234923421260726,"score_gpt":0.290370137598909,"score_spread":0.2668777954728364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}